LFWD — Lifeward Ltd.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1607962 ·
Last close
$3.10
Market Cap
$8.80M
52W High
$9.61
52W Low
$3.10
ADV30
18,661
Next earnings
2026-11-13
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 6,623,000 2,709,000 -4,152,000 -11,519,000 35,000,000 9,448,000 22,784,000
Mar 2026 3,923,000 1,342,000 -10,339,000 -10,793,000 33,419,000 11,422,000 27,128,000
Dec 2025 5,081,000 1,088,000 -5,118,000 -5,348,000 22,900,000 2,169,000 14,492,000
Sep 2025 6,195,000 2,707,000 -3,140,000 -3,170,000 23,168,000 1,956,000 10,413,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-17,077,000
Investing CF
$6,461,000
Financing CF
$14,929,000
CapEx
$-16,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-16.82
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-307,051,000
Inventory
$6,151,000
Receivables
$8,365,000
ST Investments
—
EBIT TTM
$-29,268,000
Pretax Income TTM
$-30,880,000
Interest Exp TTM
$1,286,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$21,822,000
EBITDA
$-22,982,000
Free Cash Flow
$-7,994,125
Enterprise Value
$9,038,551
Total Cash
$9,448,000
Total Debt
$6,988,000
Shares Out
2,838,715
Trailing EPS
$-15.73
Book Value
$5.52
ROE
-225.6%
ROA
-47.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 22,034,000 -16,891,000 -19,914,000 22,900,000 14,492,000 8,408,000 -16,826,000
Dec 2024 25,663,000 -19,553,000 -28,942,000 30,487,000 11,638,000 18,849,000 -21,718,000
Dec 2023 13,854,000 -23,612,000 -22,133,000 63,192,000 16,682,000 46,510,000 -20,667,000
Dec 2022 5,511,000 -19,102,000 -19,569,000 74,236,000 6,071,000 68,165,000 -17,891,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$21,822,000
NetIncome TTM
$-30,830,000
OpCashFlow TTM
—
Assets (Latest)
$35,000,000
Forward EPS
$-0.86

Peers — same industry

TickerNameMarket CapLastDaily %
PLSM Pulsenmore Ltd. $8.78M $1.35 —
RGNT REGENTIS BIOMATERIALS LTD. $8.57M $1.22 —
SINT Sintx Technologies, Inc. $9.22M $1.22 —
GTHP GUIDED THERAPEUTICS INC $8.30M $0.09 —
FEMY FEMASYS INC $9.38M $1.12 —

News headlines (Yahoo Finance, 1h cache)

Lifeward: Q3 Earnings Snapshot
2026-11-13 14:26 · Yahoo
Lifeward (LFWD) Reports Q3 Loss, Misses Revenue Estimates
2026-11-13 14:25 · Yahoo
Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-13 14:16 · Yahoo
Lifeward’s ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study
2026-10-14 12:00 · Yahoo
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
2026-09-15 12:00 · Yahoo
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
2026-09-08 12:30 · Yahoo
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer
2026-08-31 20:15 · Yahoo
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
2026-08-07 12:00 · Yahoo
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
2026-08-05 12:00 · Yahoo
BioStem Technologies, Inc. (BSEM) Reports Q3 Loss, Beats Revenue Estimates
2026-11-12 22:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.